Jay A. Markwalder

Cyclic HIV Protease Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas

Patrick Y. S. Lam, Yu Ru, Prabhakar K. Jadhav et al. · Journal of Medicinal Chemistry · 1996 · 170 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIa

Sharon Jackson, William F. DeGrado, Anil Kumar Dwivedi et al. · Journal of the American Chemical Society · 1994 · 164 citations

Pharmacy, Chemistry, Pharmacology +15

Identification and Characterization of Efavirenz Metabolites by Liquid Chromatography/Mass Spectrometry and High Field NMR: Species Differences in the Metabolism of Efavirenz

Abdul Mutlib, Hua Chen, Gregory A. Nemeth et al. · Drug Metabolism and Disposition · 1999 · 141 citations

Medicine, Pharmacokinetics, Pharmacology +15

Lipid II:  Total Synthesis of the Bacterial Cell Wall Precursor and Utilization as a Substrate for Glycosyltransfer and Transpeptidation by Penicillin Binding Protein (PBP) 1b of <i>Eschericia </i><i>c</i><i>oli</i>

Benjamin Schwartz, Jay A. Markwalder, Yi Wang · Journal of the American Chemical Society · 2001 · 134 citations

Life Sciences, Microbiology, Enzymology +16

Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors

Petra Ross‐Macdonald, Heshani de Silva, Qi Guo et al. · Molecular Cancer Therapeutics · 2008 · 128 citations

Life Sciences, Molecular Biology, Pharmacology +15